Arterial stiffness correlated with cardiac remodelling in patients with chronic kidney disease

Ming-Cheng Wang1, Wei-Chuan Tsai, Ju-Yi Chen

  • 1Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.

Nephrology (Carlton, Vic.)
|November 13, 2007
PubMed

Insights

Arterial stiffness, measured by pulse wave velocity (PWV), is linked to worsening heart remodelling in chronic kidney disease (CKD) patients. Lower PWV, higher hemoglobin, and beta-blocker use independently reduce left ventricular mass and volume indices.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biomedical Engineering

Background:

  • Chronic kidney disease (CKD) is associated with pressure and volume overload, leading to left ventricular hypertrophy (LVH) and dilatation.
  • Limited research exists on the link between arterial stiffness (pulse wave velocity, PWV) and LVH in non-dialysis CKD patients.
  • Arterial stiffness is a significant predictor of cardiovascular events in CKD.

Purpose of the Study:

  • To assess the relationship between arterial stiffness and cardiac remodeling in CKD patients.
  • To identify independent factors associated with increased left ventricular mass index (LVMI) and left ventricular volume index (LVVI).

Main Methods:

  • Cross-sectional study of 96 CKD patients.
  • Echocardiography and PWV measurements were performed.
  • Clinical and echocardiographic parameters were analyzed.

Main Results:

  • Increased PWV correlated with progressive increases in LVMI, LVH, LVVI, left ventricular dilatation, and left atrium size in CKD patients.
  • Multivariate regression identified decreased PWV, increased hemoglobin, and beta-blocker use as independent determinants for reduced LVMI and LVVI.

Conclusions:

  • Increased arterial stiffness is associated with progressive structural remodeling of the left ventricle and left atrium in CKD patients.
  • PWV is a key determinant of LVMI and LVVI in this population.
  • These findings highlight the importance of managing arterial stiffness in CKD patients to prevent cardiac remodeling.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...